Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis (Q31135042)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1 reference

Europe PubMed Central

Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

author name string

Derek J Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

John E Ray

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1451-1462

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

International interlaboratory quality control program for measurement of antiretroviral drugs in plasma

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Persistence of primary drug resistance among recently HIV-1 infected adults

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Evaluation of antiretroviral drug measurements by an interlaboratory quality control program

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Biological correlates of HIV-1 heterosexual transmission

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Modelling the effect of combination antiretroviral treatments on HIV incidence.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The prostate of the nonhuman primate: Normal anatomy and pathology

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Use of PCR to measure HIV viral changes in drug-resistant genes in genital fluids.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Limited penetration of lopinavir into seminal plasma of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of HIV-1 protease inhibitors into CSF and semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Antiretroviral drug concentrations in semen of HIV-1 infected men

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of atazanavir in seminal plasma of men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Effect of antiviral treatment on the shedding of HIV-1 in semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Passage of chemicals into human and animal semen: mechanisms and significance

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Poor penetration of the male genital tract by HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Identifiers

10.1211/JPP.59.11.0001

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31135042&oldid=1606405075"